Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × GIST × pazopanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 42 Sarcoma 20 Neoplasms 18 Neoplasm Metastasis 13 Ovarian Neoplasms 10 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Melanoma 5 Thyroid Neoplasms 4 Hemangiosarcoma 4 Fallopian Tube Neoplasms 4 Urinary Bladder Neoplasms 3 Solid Tumors 3 Recurrence 3 Prostatic Neoplasms 3 Lung Neoplasms 3 Liposarcoma 3 Leiomyosarcoma 3 Kidney Neoplasms 3 Colorectal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Carcinoma, Ovarian Epithelial 3 Sarcoma, Synovial 2 Refractory Solid Tumors 2 Neuroendocrine Tumors 2 Gliosarcoma 2 Glioblastoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2

Interventions

vandetanib 1 pazopanib 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01323400 2016-02-25

PAZOGIST

Centre Leon Berard

Phase 2 Completed

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡